This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sederma, S.a.s.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Innovations in Dermopharmaceuticals: The Work of Louis François Lamy
Introduction
Louis François Lamy, an innovative inventor based in Orlienas, France, has made significant contributions to the field of cosmetic and dermopharmaceutical compositions. With a keen focus on enhancing skin health, Lamy's work revolves around utilizing natural extracts to improve the condition of the skin and combat signs of aging.
Latest Patents
Lamy holds a patent for a cosmetic or dermopharmaceutical composition that incorporates an extract from Euglena, a microalga known for its beneficial properties. His invention is designed to activate cellular metabolism, thus providing protection and improvement to the skin, particularly in reducing signs of aging and cutaneous fatigue.
Career Highlights
Currently working at Sederma S.A.S., Lamy has dedicated his career to advancing skincare solutions through scientific research and innovation. His patent not only exemplifies his commitment to enhancing cosmetic formulations but also highlights the growing interest in biotechnological approaches in the cosmetics industry.
Collaborations
Throughout his career, Lamy has collaborated with esteemed professionals in the field, including Karl Lintner and Claire Mas Chamberlin. These partnerships have allowed for the exchange of ideas and expertise, ultimately leading to the development of ground-breaking cosmetic products that prioritize skin health and youthful appearance.
Conclusion
Louis François Lamy's innovative approach to cosmetics through the use of natural extracts underscores the potential for significant advancements in the skincare industry. His patented work reflects a growing trend towards scientific and ecological consciousness in cosmetic formulations, making him a notable figure in the realm of dermopharmaceutical innovation.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile